Philips has announced a randomized controlled trial for instant wave-Free Ratio guided percutaneous coronary intervention. It will enroll a maximum of 3,000 PCI patients at approximately 75 sites who will receive treatment with the company's angiogram and iFR platform, and angiogram-only treatment to determine which method is better.
Trial for instant wave-Free Ratio guided PCI launched by Philips
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.